Selenium biochemistry and cancer: A review of the literature

Alternative Medicine Review

Volumn 9, Issue 3, 2004, Pages 239-258

  Patrick, Lyn ^a,b  

^a Southwestern College   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BETAINE DERIVATIVE; ENZYME; ESTER; GLUTATHIONE PEROXIDASE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SE METHYLSELENOCYSTEINE; SELENITE; SELENIUM; SELENIUM DERIVATIVE; SELENOBETAINE; SELENOBETAINE METHYL ESTER; SELENOCYSTEINE; SELENOCYSTINE; SELENOMETHIONINE; SELENOPROTEIN; SELENOPROTEIN P; THIOREDOXIN REDUCTASE; THYROXINE DEIODINASE; UNCLASSIFIED DRUG;

AGING; ANTINEOPLASTIC ACTIVITY; BIOAVAILABILITY; BIOCHEMISTRY; BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLON CANCER; DEGENERATIVE DISEASE; ENZYME LOCALIZATION; EPIDEMIOLOGICAL DATA; EXPERIMENTATION; HUMAN; HYPOTHYROIDISM; INFECTION; INFERTILITY; INFLAMMATION; INTOXICATION; METABOLISM; NEUROLOGIC DISEASE; NONHUMAN; PROSTATE CANCER; REVIEW; SELENIUM DEFICIENCY; SELENOSIS; SUPPLEMENTATION; THYROID CANCER; THYROID FUNCTION; THYROID GLAND;

ANIMALS; BIOLOGICAL AVAILABILITY; HUMANS; NEOPLASMS; PROTEINS; SELENIUM; SELENOPROTEINS; THYROID GLAND;

EID: 4644325235     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Rayman MP. The importance of selenium to human health. Lancet 2000;356:233-241.
2. Behne D, Kyriakopoulos A. Mammalian selenium-containing proteins. Annu Rev Nutr 2001;21:453-473.
3. Combs GF Jr. Impact of selenium and cancer-prevention findings on the nutrition-health paradigm. Nutr Cancer 2001;40:6-11.
4. Rotruck JT, Pope AL, Ganther HE, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973;179:588-590.
5. Imai H, Nakagawa Y. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med 2003;34(2):145-196.
6. Imai H, Suzuki K, Ishizaka K, et al. Failure of the expression of phospholipid hydroperoxide glutathione peroxidase in the spermatozoa of human infertile males. Biol Reprod 2001;64:674-683.
7. Deagen JT, Butler JA, Zachara BA, Whanger PD. Determination of the distribution of selenium between glutathione peroxidase, selenoprotein P, and albumin in plasma. Anal Biochem 1993;208:176-181.
8. Maiorino M, Thomas JP, Girotti AW, Ursini F. Reactivity of phospholipid hydroperoxide glutathione peroxidase with membrane and lipoprotein lipid hydroperoxides. Free Radic Res Commun 1991;12-13:131-135.
9. Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000;346:1-8.
10. Schallreuter KU, Wood JM. The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Commun 1986;136:630-637.
11. Gallegos A, Berggren M, Gasdaska JR, Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 1997;57:4965-4970.
12. Joint Food and Agriculture Organization of the United Nations/World Food Organization of the United Nations (FAO/WHO). Expert consultation on human vitamin and mineral requirements. Manual on human nutritional requirements. September 1998.
13. th ed. Orlando, FL: Academic Press Inc; 1987:209-279.
14. Drasch G, Mail der S, Schlosser C, Roider G. Content of non-mercury-associated selenium in human tissues. Biol Trace Elem Res 2000;77:219-230.
15. Combs GF Jr, Combs SB. The nutritional biochemistry of selenium. Annu Rev Nutr 1984;4:257-280.
16. World Health Organization. Selenium, Geneva World Health Organization. Environmental Health Criteria 58.
17. Yang GQ, Zhu LZ, Liu SJ, et al. Human supplementation in China. In: Combs GR, Spallholz JE, Levander OA, Oldfield JE, eds. Selenium in Biology and Medicine. New York, NY: AVI Van Nostrand; 1984:589-607.
18. Levander OA, Morris VC. Dietary selenium levels needed to maintain balance in North American adults consuming self-selected diets. Am J Clin Nutr 1984;39:809-815.
19. Whanger PD. Selenocompounds in plants and animals and their biological significance. J Am Coll Nutr 2002;21:223-232.
20. Patterson BH, Zech LA, Swanson CA, Levander OA. Human [74Se]selenomethionine metabolism: a kinetic model. Am J Clin Nutr 1991;54:917-926.
21. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr 1998;128:1845-1854.
22. Whanger P, Vendeland S, Park YC, Xia Y. Metabolism of subtoxic levels of selenium in animals and humans. Ann Clin Lab Sci 1996;26:99-113.
23. Reid ME, Stratton MS, Lillico AJ, et al. Unpublished data.
24. Dickson RC, Tomlinson RH. Selenium in blood and human tissues. Clin Chim Acta 1967;16:311-321.
25. Kohrle J. The trace element selenium and the thyroid gland. Biochimie 1999;81:527-533.
26. Beckett GJ, Beddows SE, Morrice PC, et al. Inihibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats. Biochem J 1987;248:443-447.
27. Ramauge M, Pallud S, Esfandiari A, et al. Evidence that type III iodothyronine deiodinase in rat astrocyte is a selenoprotein. Endocrinology 1996;137:3021-3025.
28. Hawkes WC, Keim NL. Dietary selenium intake modulates thyroid hormone and energy metabolism in men. J Nutr 2003;133:3443-3448.
29. Olivieri O, Girelli D, Stanzial AM, et al. Selenium, zinc, and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to impaired selenium status. Biol Trace Elem Res 1996;51:31-41.
30. th International Symposium on Trace Elements in Man and Animals. Ottawa, Canada: NRC Research Press; 1997:201-202.
31. Tong YJ, Teng WP, Jin Y, et al. An epidemiological study on the relationship between selenium and thyroid function in areas with different iodine intake. Zhonghua Yi Xue Za Zhi 2003;83:2036-2039. [Article in Chinese]
32. Contempre B, Duale NL, Dumont JE, et al. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin Endocrinol (Oxf) 1992;36:579-583.
33. Contempre B, Dumont JE, Ngo B, et al. Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J Clin Endocrinol Metab 1991;73:213-215.
34. Ruz M, Codoceo J, Galgani J, et al. Single and multiple selenium-zinc-iodine deficiencies affect rat thyroid metabolism and ultrastructure. J Nutr 1999;129:174-180.
35. Zaichick VYe, Tsyb AF, Vtyurin BM. Trace elements and thyroid cancer. Analyst 1995;120:817-821.
36. Glattre E, Thomassen Y, Thoresen SO, et al. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol 1989;18:45-49.
37. Kohrle J, Schmutzler C, Fedete E, et al. The role of selenium in human thyroid carcinoma. Exp Clin Endocrinol 1995;103:171.
38. Dreher I, Kohrle J. The role of selenium and selenoproteins in thyroid tissue. Thyroid 1996;6:145.
39. Kucharzewski M, Braziewicz J, Majewska U, Gozdz S. Copper, zinc, and selenium in whole blood and thyroid tissue of people with various thyroid diseases. Biol Trace Elem Res 2003;93:9-18.
40. Robinson MF, Godfrey PJ, Thomson CD, et al. Blood selenium and glutathione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand. Am J Clin Nutr 1979;32:1477-1485.
41. Salonen JT, Alfthan G, Huttunen JK, Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol 1984;120:342-349.
42. Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum selenium and the risk of cancer. Lancet 1983;2:130-134.
43. Sanz Alaejos M, Diaz Romero C. Urinary selenium concentrations. Clin Chem 1993;39:2040-2052.
44. Li H, Stampfer MJ, Giovannucci EL, et al. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 2004;96:696-703.
45. Combs GF. Status of selenium in prostate cancer prevention. Br J Cancer 2004;91:195-199.
46. Hardell L, Degerman A, Tomic R, et al. Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia. Eur J Cancer Prev 1995;4:91-95.
47. Piccinini L, Borella P, Bargellini A, et al. A case-control study on selenium, zinc, and copper in plasma and hair of subjects affected by breast and lung cancer. Biol Trace Elem Res 1996;51:23-30.
48. Zachara BA, Marchaluk-Wisniewska E, Maciag A, et al. Decreased selenium concentration and glutathione peroxidase activity in blood and increase of these parameters in malignant tissue of lung cancer patients. Lung 1997;175:321-332.
49. Knekt P, Marniemi J, Teppo L, et al. Is low selenium status a risk factor for lung cancer? Am J Epidemiol 1998;148:975-982.
50. Ghadirian P, Maisonneuve P, Perret C, et al. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev 2000;24:305-313.
51. Salonen JT, Salonen R, Lappetelainen R, et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J (Clin Res Ed) 1985;290:417-420.
52. Nelson RL, Davis FG, Sutter E, et al. Serum selenium and colonic neoplastic risk. Dis Colon Rectum 1995;38:1306-1310.
53. Fex G, Pettersson B, Akesson B. Low plasma selenium as a risk factor for cancer death in middle-aged men. Nutr Cancer 1987;10:221-229.
54. Comstock GW, Bush TL, Helzlsouer K. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992;135:115-121.
55. Clark LC, Hixson LJ, Combs GF Jr, et al. Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 1993;2:41-46.
56. Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990;82:864-868.
57. Niskar AS, Paschal DC, Kieszak SM, et al. Serum selenium levels in the US population: Third National Health and Nutrition Examination Survey, 1988-1994. Biol Trace Elem Res 2003;91:1-10.
58. Ujiie S, Itoh Y, Kikuchi H. Serum selenium contents and the risk of cancer. Gan To Kagaku Ryoho 1998;25:1891-1897. [Article in Japanese]
59. Blot WJ, Li JY, Taylor PR, et al. The Linxian trials: mortality rates by vitamin-mineral intervention group. Am J Clin Nutr 1995;62:1424S-1426S.
60. Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol and subsequent bladder cancer. Cancer Res 1989;49:6144-6148.
61. Burney PG, Comstock GW, Morris JS. Serologic precursors of cancer: serum micro-nutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 1989;49:895-900.
62. Rogers MA, Thomas DB, Davis S, et al. A case-control study of oral cancer and pre-diagnostic concentrations of selenium and zinc in nail tissue. Int J Cancer 1991;48:182-188.
63. Garland M, Morris JS, Stampfer MJ, et al. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 1995;87:497-505.
64. Schrauzer GN. Anticarcinogenic effects of selenium. Cell Mol Life Sci 2000;57:1864-1873.
65. Clark LC. The epidemiology of selenium and cancer. Fed Proc 1985;44:2584-2589.
66. Clark LC, Cantor KP, Allaway WH. Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health 1991;46:37-42.
67. Clark LC, Graham GF, Crounse RG, et al. Plasma selenium and skin neoplasms: a case-control study. Nutr Cancer 1984;6:13-21.
68. Clark LC, Combs GF Jr, Turnbull BW, et al.. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-1963.
69. Combs GF Jr, Clark LC, Turnbull BW. An analysis of cancer prevention by selenium. Biofactors 2001;14:153-159.
70. Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002;11:630-639.
71. Yu SY, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res 1997;56:117-124.
72. Li B, Taylor PR, Li JY, et al. Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance. Ann Epidemiol 1993;3:577-585.
73. Wei WQ, Abnet CC, Qiao YL, et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 2004;79:80-85.
74. Hill KE, Xia Y, Akesson B, et al. Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J Nutr 1996;126:138-145.
75. Combs GF Jr, Combs S. Selenium and cancer. In: Combs GF, Combs SB, eds. The Role of Selenium in Nutrition. San Diego, CA: Academic Press; 1997:413-462.
76. th ed. Philadelphia, PA: Lippincott; 1993:1-15.
77. Combs GF Jr, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther 1998;79:179-192.
78. Kiremidjian-Schumacher L, Roy M, Wishe HI, et al. Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res 1994;41:115-127.
79. Ip C, White G. Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with vitamin E and their effects on in vitro immune functions. Carcinogenesis 1987;8:1763-1766.
80. Kiremidjian-Schumacher L, Roy M, Wishe HI, et al. Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cells. Biol Trace Elem Res 1996;52:227-239.
81. Roy M, Kiremidjian-Schumacher L, Wishe HI, et al. Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol Trace Elem Res 1994;41:103-114.
82. Bird SM, Ge H, Uden PC, et al. High-performance liquid chromatography of selenoamino acids and organo selenium compounds. Speciation by inductively coupled plasma mass spectrometry. J Chromatogr A 1997;789:349-359.
83. Ip C, Hayes C. Tissue selenium levels in selenium-supplemented rats and their relevance in mammary cancer protection. Carcinogenesis 1989;10:921-925.
84. Ganther HE, Lawrence JR. Chemical transformations of selenium in living organisms. Improved forms of selenium for cancer prevention. Tetrahedron 1997;53:12299-12310.
85. Ip C, Ganther HE. Relationship between the chemical form of selenium and anticarcinogenic activity. In: Wattenberg L, Lipkin M, Boone CW, Keloff GJ, eds. Cancer Chemoprevention. Boca Raton, FL: CRC Press; 1992:479-488.
86. Ip C, Zhu Z, Thompson HJ, et al. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Res 1999;19:2875-2880.
87. Ip C, Lisk DJ, Thompson HJ. Selenium-enriched garlic inhibits the early stage but not the late stage of mammary carcinogenesis. Carcinogenesis 1996;17:1979-1982.
88. Brown T, Shrift A. Exclusion of selenium from proteins of selenium-tolerant Astragalus species. Plant Physiol 1981;67:1061-1081.
89. Ip C, Birringer M, Block E, et al. Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention. J Agric Food Chem 2000;48:2062-2070.
90. Medina D, Thompson H, Ganther H, Ip C. Semethylselenocysteine: a new compound for chemoprevention of breast cancer. Nutr Cancer 2001;40:12-17.
91. McConnell KP, Jager RM, Bland KI, Blotcky AJ. The relationship of dietary selenium and breast cancer. J Surg Oncol 1980;15:67-70.
92. Subramaniam S, Shyama S, Jagadeesan M, et al. Oxidant and antioxidant levels in the erythrocytes of breast cancer patients treated with CMF. Med Sci Res 1993;21:79-80.
93. Capel ID, Williams DC. Selenium and glutathione peroxidase in breast cancer. IRCS Med Sci Biomed Technol 1979;7:425.
94. Hardell L, Danell M, Angqvist CA, et al. Levels of selenium in plasma and glutathione peroxidase in erythrocytes and the risk of breast cancer. A case-control study. Biol Trace Elem Res 1993;36:99-108.
95. Schrauzer GN, Molenaar T, Mead S, et al. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Jpn J Cancer Res 1985;76:374-377.
96. Mannisto S, Alfthan G, Virtanen M, et al. Toenail selenium and breast cancer - a case-control study in Finland. Eur J Clin Nutr 2000;54:98-103.
97. Hunter DJ, Morris JS, Stampfer MJ, et al. A prospective study of selenium status and breast cancer risk. JAMA 1990;264:1128-1131.
98. van den Brandt PA, Goldbohm RA, van't Veer P, et al. Toenail selenium levels and the risk of breast cancer. Am J Epidemiol 1994;140:20-26.
99. van't Veer P, van der Wielen RP, Kok FJ, et al. Selenium in diet, blood, and toenails in relation to breast cancer: a case-control study. Am J Epidemiol 1990;131:987-994.
100. Dorgan JF, Sowell A, Swanson CA, et al. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes Controls 1998;9:89-97.
101. Garland M, Morris JS, Rosner BA, et al. Toenail trace element levels as biomarkers; reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 1993;2:493-497.
102. Clark LC, Alberts DS. Selenium and cancer: risk or protection. J Natl Cancer Inst 1995;87:473-475.
103. Ip C, Lisk DJ, Stoewsand GS. Mammary cancer prevention by regular garlic and selenium-enriched garlic. Nutr Cancer 1992;17:279-286.
104. Ankerst J, Sjogren HO. Effect of selenium on the induction of breast fibroadenomas by adenovirus type 9 and 1,2-dimethylhydrazine-induced bowel carcinogenesis in rats. Int J Cancer 1982;29:707-710.
105. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
106. Milde D, Novak O, Stu ka V, et al. Serum levels of selenium, manganese, copper and iron in colorectal cancer patients. Biol Trace Elem Res 2001;79:107-114.
107. van den Brandt PA, Goldbohm RA, van't Veer P, et al. A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. J Natl Cancer Inst 1993;85:224-229.
108. Pawlowicz Z, Zachara BA, Trafikowska U, Nowicki A. Low levels of selenium and activity of glutathione peroxidase in blood of patients with gastrointestinal neoplasms. Pol Tyg Lek 1993;48:554-556. [Article in Polish]
109. Reddy BS, Hirose Y, Lubet RA, et al. Lack of chemopreventive efficacy of DL-selenomethionine in colon carcinogenesis. Int J Mol Med 2000;5:327-330.
110. Finley JW, Davis CD. Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate, and selenomethionine, but is more effective in inhibiting colon carcinogenesis. Biofactors 2001;14:191-196.
111. Davis CD, Zeng H, Finley JW. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr 2002;132:307-309.
112. Yoshizawa K, Willett WC, Morris JS, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-1224.
113. Morris JS, Stampfer MJ, Willet WC. Dietary selenium in humans: toenails as an indicator. Biol Trace Elem Res 1983;5:529-537.
114. Helzlsouer KJ, Huang HY, Alberg AJ, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 2000;92:2018-2023.
115. Taylor PR, Albanes D. Selenium, vitamin E and prostate cancer - ready for prime time? J Natl Cancer Inst 1998;90:1184-1185.
116. Marshall JR. Larry Clark's legacy: randomized, controlled, selenium-based prostate cancer chemoprevention trials. Nutr Cancer 2001;40:74-77.
117. Mary Reid, PhD, Roswell Park Cancer Institute. Personal communication.
118. Ghosh J. Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun 2004;315:624-635.
119. Federico A, Iodice P, Federico P, et al. Effects of selenium and zinc supplementation on nutritional status in patients with cancer of the digestive tract. Eur J Clin Nutr 2001;55:293-297.
120. Sieja K, Talerczyk M. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol 2004;93:320-327.
121. Kiremidjian-Schumacher L, Roy M. Effect of selenium on the immunocompetence of patients with head and neck cancer and on adoptive immunotherapy of early and established lesions. BioFactors 2001;14:161-168.